« Translational Medicine

Translational Medicine Forum on PhDG

Viswanatha
April 22, 2008 10:58AM
Group Manager
Posts: 102

Dear Friends,

Why a new forum?

Among the various topics under discussion on PhDG, time & again many have touched upon issues such as Role of Traditional Medicine Knowledge in Drug Development, Radical Transparency in reporting clinical outcomes, Reverse Pharmacology approach for accelerating new therapeutics etc…but sooner the original issue catches up & these remain mere flash in the pan’ – I felt that having a separate forum may help keep these really important issues alive & in spot-light…… hence the “Translational Medicine Forum”

While much attention has been given “Bench to Bed Side” i.e. on testing the theories emerging from preclinical experimentation on disease-affected human subjects; the “Bed Side to Bench” approach wherein information obtained from preliminary human experimentation can be used to refine our understanding of the biological principles underpinning the heterogeneity of human disease and polymorphism(s) has been largely ignored.

The above text is a ‘partially rearranged’ extract from the Journal of Translational Medicine which is an open access (wow!), peer-reviewed online journal focusing on information derived from human experimentation so as to optimize the communication between basic and clinical science.

The Journal of Translational Medicine works on the principle that “the Results of a clinical study originating from a sound scientific rationale should be considered equally important, whether the outcome is negative or positive” – The supposition here is that 1) knowledge of negative results will discourage researchers from publishing a similar study & 2) important biological information could offer important insights into the reasons for failure and suggest remedies - Journal of Translational Medicine therefore aims to provide a home just for this kind of information. Access more information at http://www.translational-medicine.com

While Journal of Translational Medicine can be used as a resource for any discussions in this forum, members are encouraged to share other topics too (out side the gamut of JTM) but relevant to TM.

I look forward to some insightful & interesting topics here in the days to come……

Edited: April 24, 2008 11:21PM
Show

Replies to this Topic


Nick
April 22, 2008 12:55PM
Group Member
Posts: 12

I'm as interested as it's possible to be as a lay person.

I am an executive search consultant in life sciences and was lucky enought o support more than one major pharmaceutical organisation in transforming "clinical pharmacology" departments into "translational mediciine" centres during the mid 1990's. I have been fascinated ever since.

I believe that T M is potentially the new approach that will re connect the relationship between investment and return in drug development (half of the cause of Pharma's woes) AND that it  will give regulators comfort in allowing smaller, more focussed trials AND that it should open the door to real personalised medicine.

The data pharma can now gather could lead to truly rational drug design, and that in the end will benefit patients....which is why we all joined this industry.

 

Devesh
June 04, 2008 05:00PM
Group Member
Posts: 14

Friends,

I want to share this latest information with all of you.....

We have been discussing in our other forums about need to integrate traditional medicine therapies with Allopathy

Here is an example :

Miracle Cure for Malaria

 Scientists at the University of California, Berkeley, are relying on synthetic biology to produce sufficient amounts of a medicine based on an ancient Chinese herbal remedy, to protect over a million children who die each year from malaria.

The drug called artemisinin is based on extracts from the Chinese plant Artemesia annua (sweet wormwood), which has been used in China to treat malaria since at least the second century BC.

It is said to be too expensive for the majority of people in developing countries who contract malaria from mosquito bites.

The scientists now believe that synthetic biology, wherein genetically engineered microbes with implanted artificial chromosomes (gene "cassettes") are grown in giant fermenting vats may help make enough quantities of the drug in a single bioreactor within two years to supply the needs of up to 500 million people suffering from malaria, at a 10th of the cost of existing drugs.

They say that producing a semi-synthetic form of artemisinin on an industrial scale using a single bioreactor, as big as a three-storey town house, might cut its price to an extent that it would become the cheapest and most effective anti-malarial drug on the market.

Professor Jay Keasling of the University of California, Berkeley, said that the low price and widespread availability of the semi-synthetic drug could help undermine the counterfeit market in artemisinin, which increases the risk of drug resistance as well as doing little to help malaria patients.

"We want it to be affordable to people who need it, to be available to people who need it, and we don't want it to be abused," the Independent quoted Professor Keasling as saying, during a two-day conference on synthetic biology at the Royal Society in London.

"The process is very similar to brewing beer but we're talking about turning on 12 genes simultaneously in the genetically engineered yeast cells and controlling their outputs to balance the metabolic pathway leading to artemisinin," he added.

He revealed that the work on the new approach to making the medicine started with a grant of $ 42.6 million (about Rs 170 crore) from the Bill and Melinda Gates Foundation, and that it was being taken into industrial production with the help of the French company Sanofi Aventis.

He also revealed that Sanofi Aventis would be building a bioreactor in Europe by 2010, which would produce continuous amounts of the drug in sufficient quantities to treat the 500 million people a year who develop malaria.

Professor Keasling said that producing semi-synthetic artemisinin on an industrial scale would also undermine speculators who had hoarded stockpiles of the wild plant, raising prices fourfold.

"We can drive down costs, hitting the market price at its launch and significantly reducing costs further over time," he said.

There is a light at the end of the tunnel, we have to be postive & honest in our approach

Regards,

Devesh

Nick
June 05, 2008 02:03PM
Group Member
Posts: 12

Artemesin is vey old news my friend. Good news but old.

Great example of how "Traditional" cures can become "modern" cures and of how "Alternative" therapies become "medicines" when someone invests time and money on proving they work and are safe.

 


Post a Reply

You must be logged in and be a member of this group in order to post a reply to this topic.
Click here to join this group.

Feed RSS Feed for this Topic

728x90-advertisehere
powered by CollectiveX